Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myelomaJithma P. Abeykoon, Prashant Kapoor, Bonnie K. Arendt et al.|British Journal of Haematology|2020Cited by 30
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myelomaSaurabh Zanwar, Shaji Kumar, Dragan Jevremović et al.|Blood Cancer Journal|2025Cited by 8
<scp>FDA IDE</scp> validation of multiple myeloma <scp>MRD</scp> test by flow cytometryDragan Jevremović, Horatiu Olteanu, Min Shi et al.|American Journal of Hematology|2024Cited by 7